Dexamethasone with netilmicin
Brand names: specials
This combined ophthalmic preparation contains the corticosteroid dexamethasone with the aminoglycoside antibiotic netilmicin, used for inflammatory eye conditions where a susceptible bacterial infection is present or likely.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
Dexamethasone dampens ocular inflammation by inhibiting inflammatory mediators, while netilmicin binds the bacterial 30S ribosomal subunit to inhibit protein synthesis, giving bactericidal activity against many Gram-negative and some Gram-positive organisms.
Prescribing in practice
- Topical corticosteroids are contraindicated in undiagnosed red eye and suspected herpes simplex (dendritic) keratitis because of the risk of corneal melt and perforation, so a herpetic cause must be excluded.
- Prolonged use carries the risk of steroid-induced glaucoma, cataract and masking of infection, so courses should be short and ophthalmologist-led.
- Aminoglycosides can cause local hypersensitivity and surface toxicity; discontinue if irritation or allergy develops.
Monitoring
With more than brief use, monitor intraocular pressure and review the cornea and treatment response, stopping if infection worsens or hypersensitivity occurs.
Counselling the patient
- Use only for the prescribed short course and do not self-restart for later eye symptoms.
- Seek advice if the eye becomes more painful, red or swollen.
- Remove contact lenses during treatment unless advised otherwise.
Evidence & guidelines
Combined corticosteroid-aminoglycoside eye preparations are well established for inflammatory ocular conditions with a bacterial component, with safe use contingent on excluding viral keratitis and limiting duration.
Reference: RCOphth; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- Steroid Dose Equivalence · Medications
- Adrenal Crisis Risk Score · Adrenal Disorders
- Ideal Body Weight (Devine) · Anthropometry
- Lille Model (Steroid Response in Alcoholic Hepatitis) · Alcoholic Liver Disease
- Ho Index for Predicting Response to Medical Therapy in IBD · Inflammatory Bowel Disease
- Apfel Score for Postoperative Nausea and Vomiting · Perioperative
- Acute Red Eye / Vision Loss Screen · RCOphth 2020; NICE CKS
- Idiopathic Intracranial Hypertension · ABN; consensus 2018
- Acute Red Eye Assessment · RCOphth / AAO
- Acute Angle Closure Glaucoma · RCOphth / EGS Guidelines
- Retinal Detachment · RCOphth Guidelines / EURETINA
- Diabetic Retinopathy — Screening and Management · NICE NG28 2016 / NHS DES Programme